• No results found

[PDF] Top 20 High levels of factor XI and the risk of venous thrombosis

Has 10000 "High levels of factor XI and the risk of venous thrombosis" found on our website. Below are the top 20 most common "High levels of factor XI and the risk of venous thrombosis".

High levels of factor XI and the risk of venous thrombosis

High levels of factor XI and the risk of venous thrombosis

... Also, when we excluded subjects who had known genetic risk factors for thrombosis (e.g., protein C or S deficiency, antithrombin deficiency, the factor V Lei- den mutation, orthe prothro[r] ... See full document

6

High levels of factor IX increase the risk of venous thrombosis

High levels of factor IX increase the risk of venous thrombosis

... oral contraceptive use at the time of thrombosis äs well äs at the time of venipuncture, and high levels of factor VIII, XI, and the vitamin K-dependent clotling factors (all dichotomize[r] ... See full document

5

Procoagulant factors and the risk of myocardial infarction in young women

Procoagulant factors and the risk of myocardial infarction in young women

... VWF levels were not only associated with arterial thrombosis (13, 34) but also with a history of diabetes and hypertension (35, ...brand factor is essential in primary haemostasis: it serves as the ... See full document

7

Risk factors for a first and recurrent venous thrombosis

Risk factors for a first and recurrent venous thrombosis

... than venous thrombosis were censored at date of ...57months). High levels of prothrombin, factor VII activity, factor VIII activity, factor IX antigen, factor X ... See full document

134

Factor V levels and risk of venous thrombosis: The MEGA case-control study

Factor V levels and risk of venous thrombosis: The MEGA case-control study

... relative risk of VT for factor V levels and adjusted for age and sex using logistic ...FVIII levels was performed to study the associ- ation between these two ...The risk estimates were ... See full document

7

<p>Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk</p>

<p>Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk</p>

... and high sensitive C-reactive protein (hsCRP) levels were determined according to previously described ...C levels were performed with a chro- mogenic assay and factors II, VII, VIII, X and XI ... See full document

9

Venous Thromboembolism in Adolescents

Venous Thromboembolism in Adolescents

... elevated factor viii upon the diagnosis of vte. in five patients factor viii was checked, when the oral anticoagulation was stopped, in 4 patients the Fviii level was not repeated or there are still on ... See full document

5

Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads

Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads

... Established risk factors for venous thrombosis were as- sessed in detail for all ...of venous thrombosis, use of female hormones (oral contra- ceptives, hormone replacement therapy), ... See full document

5

Venous and arterial thrombosis : associations and risk factors

Venous and arterial thrombosis : associations and risk factors

... tissue factor (TF)/factor (F) VIIa complex that can activate FIX or ...At high TF concentrations, FX is activated primarily by the TF/FVIIa complex, whereas at low TF concentrations, the contribution ... See full document

187

THE INCIDENCE OF F8 GENE MUTATION IN SUDANESE PATIENTS AT RISK OF BOTH VENOUS AND ARTERIAL THROMBOSIS UNDER PROLONG USE OF WARFARIN TREATMENT

THE INCIDENCE OF F8 GENE MUTATION IN SUDANESE PATIENTS AT RISK OF BOTH VENOUS AND ARTERIAL THROMBOSIS UNDER PROLONG USE OF WARFARIN TREATMENT

... higher risk of treatment failure and /or thrombus formation than ...of thrombosis, high range of dose and patient with other ...of thrombosis (6.2%) than males which had an incidence of ... See full document

14

Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis

Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis

... Individuais with the factor XIII 34Leu allele had a higher factor XIII dissociation mdex under conditions of controlled m vitro activation of factor XIII These results mdicate that, unde[r] ... See full document

7

Lower extremity venous thrombosis in patients younger than 50 years of age

Lower extremity venous thrombosis in patients younger than 50 years of age

... observed risk factor for venous thrombosis among patients younger than 50 years, with an increased prevalence of at least threefold compared with the control ...in high risk ... See full document

7

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

... the risk of thrombosis reported in the literature, we can rank oral contraceptives by estrogen dose and progestogen ...type. High-dose oral contraceptives containing $ 50 mg ethinylestradiol have ... See full document

6

Research Article A Study to Find Out the Proportion of Patients with Deep Vein Thrombosis among Those Evaluated For Suspected Pulmonary Embolism

Research Article A Study to Find Out the Proportion of Patients with Deep Vein Thrombosis among Those Evaluated For Suspected Pulmonary Embolism

... deep venous thrombosis which was first described by Loud et al in ...deep venous thrombosis i.e. venous thromboembolic disorder as whole is possible by a single examination 13 ... See full document

11

Estrogen plus progestin and risk of venous thrombosis

Estrogen plus progestin and risk of venous thrombosis

... and risk of vascular outcomes was conducted af- ter early findings indicated increased vascular risk in women taking estro- gen plus ...for factor V Leiden (n = 615), prothrombin G20210A (n = 616), ... See full document

8

Venous and arterial thrombosis: Two aspects of the same disease?

Venous and arterial thrombosis: Two aspects of the same disease?

... between venous and arterial ...several risk factors, such as age, obesity, diabetes mellitus, blood hypertension, hypertriglyceridemia, and metabolic ...both venous and arterial thrombosis, ... See full document

6

Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score

Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score

... Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA study) 92.. were used.[r] ... See full document

24

Noncontrast CT in Deep Cerebral Venous Thrombosis and Sinus Thrombosis: Comparison of its Diagnostic Value for Both Entities

Noncontrast CT in Deep Cerebral Venous Thrombosis and Sinus Thrombosis: Comparison of its Diagnostic Value for Both Entities

... patients from the control group had been performed under exactly the same conditions. This provides evidence that the observed value of NCCT in the diagnosis of DVT compared with SVT does not result from the improvement ... See full document

8

Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India

Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India

... of Thrombosis & Hemostasis [8] by using screen- ing and confirmatory reagents LA1 & LA2 (Dade Behring, Marburg Germany), Kaolin clotting time and dilute PT ... See full document

5

High prevalence of antinuclear antibodies in patients following venous thromboembolism

High prevalence of antinuclear antibodies in patients following venous thromboembolism

... reversible risk factor (such as surgery, trauma, im- mobilization, pregnancy, oral contraceptive use or hormone replacement therapy) within the last 6 weeks to 3 months before diagnosis, and “unprovoked” in  ... See full document

6

Show all 10000 documents...